Hanbury FZE
  • Search
  • Home
  • Products & Services
    • Nutraceutical Ingredients
      • Standardized Phyto Extracts
      • Beverage/Liquid Dietary Supplements
      • GRAS Affirmed Ingredients
      • Minerals for Nutritional Use
      • Phytochemicals for Nutritional Use
      • Multi-enzyme Blends
      • Natural Protein
      • Nutritional Fine Chemicals
      • Phyto Functional Blends
      • Geroceuticals™
      • Prebiotics, Probiotics, Postbiotics and Synbiotics
      • Super Critical Fluid (SCF) Extracts
      • Specialty Fine Chemicals
    • Cosmeceutical Ingredients
      • Natural Actives
      • Peptides
      • Anti-Glycation
      • Dermaceuticals
      • Nutricosmetics
      • Probiotics & Postbiotics
      • Proprietary Cosmeceutical Blends
      • Speciality Chemicals
    • Services
      • Custom Manufacturing
      • Contract Manufacturing
      • Product Specification Sheet
    • Pharma
      • Natural Drugs
      • Chiral Drug Intermediates
  • About Us
    • Our Story
    • Our People
    • Research & Development
    • Manufacturing Facilities
    • Intellectual Properties
  • Newsroom
    • Press Release
    • FAQs
      • BioPerine®
      • Citrin®K
      • Cococin™
      • Curcumin C3 Complex®
      • Curcumin C3 Reduct®
      • ForsLean®
      • GarCitrin®
      • LactoSpore®
      • LeanGard®
  • Contact Us

Home / Dr. Muhammed Majeed Names Ms. Asha Ramesh CEO of Sabinsa USA

Dr. Muhammed Majeed Names Ms. Asha Ramesh CEO of Sabinsa USA

Dr. Muhammed Majeed Names Ms. Asha Ramesh CEO of Sabinsa USA

Dr. Muhammed Majeed, founder of Sabinsa, is pleased to announce that he has promoted Ms. Asha Ramesh to the position of CEO for Sabinsa USA. She will also join the company’s Board of Directors.

“Asha is well suited to oversee Sabinsa’s US division, given her many years of experience with several aspects of the company. She has a keen understanding of the company’s principles, vision, and mission,” Dr. Majeed said. “From her experience on the R&D and manufacturing side with Sami Labs in India, she knows our deep commitment to science, innovation, and quality, and from her US sales experience, she understands well how the company best meets the needs of our customers.”

Asha has been with the Sami-Sabinsa Group over two decades, most recently as Sabinsa’s Vice President of Business Development. She joined the Group 24 years ago as Manager of Purchasing & Special Projects at Sabinsa’s parent company, Sami Labs Ltd. in Bangalore, India. She moved to the Sabinsa staff in January 2000, focusing primarily on sales and business development with involvement in a range of departments of the organization.

“Asha has been instrumental in building strong business relationships and growing sales for the company; her qualifications and experience give her an excellent background for leading our US division,” said Sabinsa President-worldwide Shaheen Majeed. “We thank outgoing CEO Mr. Jayasankar Nair for his service and are pleased that he will be retained as Senior Advisor to the Group.”

“I’m excited about my new role and look forward to continuing to work with customers and the fantastic Sabinsa team to accomplish higher achievements, strategically,” Asha said. “It will be my endeavor to remain committed to the Company’s mission of providing the highest quality ingredients supported by strong science and excellent customer service to the natural products industry.”

Asha has a Bachelor’s Degree in Science and an MBA with specialization in Marketing Management from Bangalore University, India.

Back
top

HEADQUARTERS

Hanbury FZE


Jebel Ali Free Zone


Warehouse No. RA08AB05


P O Box. 61091


Dubai


United Arab Emirates


+971 4 883 8981

+971 4 883 8978

mail@hanburyfze.ae

CERTIFICATES

Certificate Logos Certificate Logos Certificate LogosCertificate Logos

Global Contacts List

USA India
Utah, USA Japan
Australia Poland
Brasil Korea
Canada South Africa
China Vietnam
Germany  

CONTACT US

    © 2023 Hanbury FZE. All Rights Reserved | Powered by Edkal Technologies | Privacy Policy | Terms of Use | Sitemap | Disclaimer

    • Facebook
    • Twitter
    • LinkedIn
    Disclaimer

    US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

    EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.